News

Medical school labs pivot to fight a common enemy

The proverbial saying ‘Necessity is the mother of invention’ is frequently used to explain how great innovations are made during times of urgent need. Never has the need been direr than when the COVID pandemic hit in March 2020 and health care providers were struggling to find treatments for patients fighting this new and deadly […]

Measuring mitochondrial DNA could predict who will need ICU care, intubation

January 13 blogpost, “Fight Against COVID-19 Aided by Sepsis Researchers” features Richard Hotchkiss, MD and Kenneth Remy, MD. Read the entire blog post here.

Virtual talk also open to general public

Lecture hosted by Department of Medicine will be available online to public

Discovery could aid early screening, shed light on how Chiari malformation arises

This episode of ‘Show Me the Science’ contrasts the rapid development of effective vaccines with the lack of progress toward effective therapies

At its December 17, 2020, board meeting the City of St. Louis Boards of Health and Hospitals announced the unanimous selection of Rhonda Belue, PhD as its new Board Chairperson. BeLue has served on the board since March 2017 and succeeds Dr. Will Ross as chairperson. Dr. Ross will continue serving on the board. 

Researchers at the Brown School at Washington University in St. Louis are conducting discussion groups with parents and staff in the Special School District of St. Louis County (SSD) to develop communication tools surrounding COVID-19 testing and vaccination.

Employees with close patient contact begin receiving Pfizer vaccine; older ages prioritized

The Fall 2020 Skandalaris LEAP cycle has ended and a new set of translational research projects have been funded. LEAP is an asset development program and gap fund designed to provide intellectual and financial capital to WashU affiliate translational projects.

Researchers at Washington University School of Medicine in St. Louis have received a two-year, $5 million grant to offer 50,000 saliva tests for the SARS-CoV-2 virus to students, teachers and staff in the six special education schools operated by the Special School District of St. Louis County (SSD).

Findings indicate anti-inflammatory drugs likely to benefit only a fraction of people with severe disease

A look at how Washington University came together in the spring and summer to respond to the COVID-19 outbreak — and to prepare for a fall semester that is anything but back to normal.

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen […]

New findings from researchers at Washington University School of Medicine in St. Louis suggest the eye’s cornea can resist infection from the novel coronavirus. Although the herpes simplex virus can infect the cornea and spread to other parts of the body in patients with compromised immune systems, and Zika virus has been found in tears […]

Rachel Presti, MD, PHD is the director of Washington University’s Infectious Diseases Clinical Research Unit and principal investigator for WashU’s COVID-19 vaccine trials. Sharon Frey, MD, is clinical director for SLU’s Center for Vaccine Development and principal investigator for SLU’s vaccine trials. Presti and Frey are coordinating so the two institutions can lead different vaccine […]

Lindsay to serve as co-chair for the Patient-Centered Outcomes Research Institute’s (PCORI) Advisory Panel on Rare Diseases, one of five multi-stakeholder advisory panels.

Phase 3 trial involves hospitalized patients with moderate to severe disease